Era-Net (MOH): ERA4Health: Nano and Advanced Technologies for Disease Prevention, Diagnostic and Therapy (NANOTECMEC) (Pre-proposals)

The program supports consortia of minimum 3 partners eligible for funding (see in the call) from 3 different countries.

Project proposals will address multidisciplinary and translational research. The applications must cover at least one of the following nanomedicine areas that are of equal relevance for this call:

1. a) Regenerative medicine
2. b) Diagnostics
3. c) Nanotherapy

Proposals may include, but are not limited to the identification, characterisation and validation of biomarkers, early diagnosis, convergence of nanotechnology and stem cell technology, cell biology applied to nanomedicine, multimodal imaging agents or techniques, point of care diagnostics (on site sensors), standardised procedures for preparation & characterisation of drug delivery systems, green production processes for nanomedical products, nanoparticles for hyperthermia, regenerative, gene or cell therapies using nanotechnology.

Funding for the Israeli partner: €140,000 over 3 years. (€180K for coordinator)

* A short abstract and budget should be sent to the ministry of Health (MOH) prior to pre-proposal submission. Call us for clarifications and MOH abstract forms (tel. 2152, 1272).

https://era4health.eu/

https://era4health.eu/pre-announcement-of-the-nano-and-advanced-technologies-for-disease-prevention-diagnostic-and-therapy-nanotecmec-call/

An informational webinar will be held on November 21, at 11:00, register to attend the webinar